SUMMIT VETERINARY PHARMACEUTICALS LIMITED

Active

Registry details

Reference data exactly as held at Companies House.

Copy registry details
Registered office
Birchin Court 5th Floor, 19-25 Birchin Lane, London EC3V 9DU
Accounts type
Small

Company activity

The 4 most recent documents filed at Companies House.

Pre-Score for UK companies is coming soon
  1. 17/07/2026

    Confirmation statement made on 2026-07-01 with no updates

    View PDF (3 pages)
  2. 30/04/2026

    Accounts for a small company made up to 2025-12-31

    View PDF (12 pages)
  3. 15/08/2025

    Confirmation statement made on 2025-08-12 with updates

    View PDF (5 pages)
  4. 15/07/2025

    Current accounting period shortened from 2026-03-31 to 2025-12-31

    View PDF (1 pages)

Accounts and confirmation statement

The two filings Companies House requires every year, and where each one stands against its deadline today.

Annual accounts

Small accounts

On schedule

30/09/2027Filing deadline

Next accounts made up to
31/12/2026
Last accounts made up to
31/12/2025

Confirmation statement

Confirms the registry record is up to date

On schedule

15/07/2027Filing deadline

Next statement date
01/07/2027
Last statement dated
01/07/2026

See the full filing history

Financial performance

The latest figures SUMMIT VETERINARY PHARMACEUTICALS LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.

Net Assets

£5.13M2025
66.84%vs 2024

2024: £3.08M

Total Assets

£7.94M2025
47.21%vs 2024

2024: £5.39M

Cash in Bank

£1.72M2025
186.81%vs 2024

2024: £600.27K

Total Liabilities

£1.67M2025
45.80%vs 2024

2024: £1.15M

Employees

02025
-35vs 2024

2024: 35

Of the 4 measures with an earlier filing to compare against, 4 rose. Total assets moved furthest, up 47.21% on 2024. See the full financial analysis for SUMMIT VETERINARY PHARMACEUTICALS LIMITED.

Employees

Headcount as reported to Companies House for 2021–2025.

272021
292022
342023
352024
02025
YearEmployeesChange
20250-35
202435+1
202334+5
202229+2
202127–

Reported employee count decreased from 27 in 2021 to 0 in 2025. See how headcount moved alongside the reported financials.

Credit report

It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.

Officers

6

Directors, secretaries and other appointed officers, with the period each has served.

PersonRolePeriodConnected companies
Director15/07/2010–Present2
Corporate Secretary12/08/2009–09/08/2013182
Director01/04/2025–Present0
Director01/04/2025–Present2
Director12/08/2009–Present2
Corporate Secretary09/08/2013–Present167

Persons with significant control

5

Individuals or entities with significant control over the company, as declared to Companies House.

PersonPeriodConnected companies
06/04/2016–01/04/20252
06/04/2016–Present2
06/04/2016–Present2
01/04/2025–Present2
06/04/2016–01/04/20252

Filing history and recent activity

Every document on the Companies House record, newest first.

Filings on record
21
Since 31/10/2022
Last 12 months
2
-6 vs the year before
Most recent filing
17/07/2026
2 months ago

What changed in the last year

  • Confirmation statementLatest 17/07/2026
  • Accounts filedLatest 30/04/2026

Filing timeline

  1. 17/07/2026

    Confirmation statement made on 2026-07-01 with no updates

    View PDF (3 pages)
  2. 30/04/2026

    Accounts for a small company made up to 2025-12-31

    View PDF (12 pages)
  3. 15/08/2025

    Confirmation statement made on 2025-08-12 with updates

    View PDF (5 pages)
  4. 15/07/2025

    Current accounting period shortened from 2026-03-31 to 2025-12-31

    View PDF (1 pages)
  5. 09/07/2025

    Total exemption full accounts made up to 2025-03-31

    View PDF (16 pages)
  6. 04/04/2025

    Cessation of Stephen Daniel Organ as a person with significant control on 2025-04-01

    View PDF (1 pages)
  7. 04/04/2025

    Cessation of Laura Michiko Organ as a person with significant control on 2025-04-01

    View PDF (1 pages)
  8. 04/04/2025

    Appointment of Mr Hakan Lagerberg as a director on 2025-04-01

    View PDF (2 pages)
  9. 04/04/2025

    Appointment of Mr John Kane as a director on 2025-04-01

    View PDF (2 pages)
  10. 04/04/2025

    Notification of Swedencare Ab (Publ) as a person with significant control on 2025-04-01

    View PDF (2 pages)
  11. 19/08/2024

    Confirmation statement made on 2024-08-12 with updates

    View PDF (4 pages)
  12. 19/08/2024

    Total exemption full accounts made up to 2024-03-31

    View PDF (16 pages)

Showing 12 of 21 filings

See when the next accounts and confirmation statement are due

Similar companies

8 UK companies are similar to SUMMIT VETERINARY PHARMACEUTICALS LIMITED, sharing the same company status (Active), the same industry sector and activity group (Manufacture of basic pharmaceutical products) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.

8 UK companies share this business profileThe 5 above are the closest matches. See every UK company registered under Manufacture of basic pharmaceutical products.Browse the listing

About SUMMIT VETERINARY PHARMACEUTICALS LIMITED

A short description of the company, written from its Companies House record.

SUMMIT VETERINARY PHARMACEUTICALS LIMITED is a private limited company registered in the United Kingdom, based in Birchin Court 5th Floor, 19-25 Birchin Lane, London EC3V 9DU. Companies House classifies its business as Manufacture of basic pharmaceutical products. It has been on the register for 17 years 1 month.

The register currently records it as active. Its 2025 accounts report net assets of £5.13M and 0 employees.

SUMMIT VETERINARY PHARMACEUTICALS LIMITED: frequently asked questions

Answered from this company's own registry record and filed figures.

Companies House records SUMMIT VETERINARY PHARMACEUTICALS LIMITED under one registered business activity: Manufacture of basic pharmaceutical products (21.10 - SIC 2007).

SUMMIT VETERINARY PHARMACEUTICALS LIMITED is recorded as active on the Companies House register, and has been on it since 12/08/2009.

The most recent accounts Okredo holds cover 2025 and report net assets of £5.13M, total assets of £7.94M, cash in bank of £1.72M and total liabilities of £1.67M.

The most recent document on the record is dated 17/07/2026: Confirmation statement made on 2026-07-01 with no updates, 2 months ago.

On the current registry record, accounts are due by 30/09/2027 and the next confirmation statement is due by 15/07/2027.

Companies House lists 6 officers (5 currently in post) and 5 people with significant control (3 current).